Walleye Capital
PRNB

Walleye Capital’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Walleye Capital’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,280
Closed -$563K – 2013
2019
Q4 		$563K Buy
+10,280
New +$384K 0.04% 621

Other funds holding PRNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Walleye Capital's PRNB Position: Q1 2020 in Review

Walleye Capital sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q1 2020, closing a stake of 10,280 shares — an estimated $563K sold.

Walleye Capital first reported a position in PRNB in Q4 2019 and held it in 1 quarter. The position peaked at $563K in Q4 2019. 118 funds tracked by Wall St. Rank hold PRNB as of Q1 2020.

  • Walleye Capital reported no remaining Principia Biopharma Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Walleye Capital sold 10,280 Principia Biopharma Inc. Common Stock shares in Q1 2020, an estimated $563K.
  • Walleye Capital first reported a position in Principia Biopharma Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Walleye Capital's Principia Biopharma Inc. Common Stock position peaked at $563K in Q4 2019.
  • 118 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q1 2020.

Based on Walleye Capital's 13F filing for Q1 2020, filed 15 May 2020.